CN1129938A - 作用于AMPA受体的烷氧基取代的β-咔啉 - Google Patents

作用于AMPA受体的烷氧基取代的β-咔啉 Download PDF

Info

Publication number
CN1129938A
CN1129938A CN94193211A CN94193211A CN1129938A CN 1129938 A CN1129938 A CN 1129938A CN 94193211 A CN94193211 A CN 94193211A CN 94193211 A CN94193211 A CN 94193211A CN 1129938 A CN1129938 A CN 1129938A
Authority
CN
China
Prior art keywords
alkyl
compound
formula
lin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94193211A
Other languages
English (en)
Chinese (zh)
Inventor
D·塞德曼
L·特斯基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of CN1129938A publication Critical patent/CN1129938A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN94193211A 1993-08-31 1994-08-29 作用于AMPA受体的烷氧基取代的β-咔啉 Pending CN1129938A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4330175.4 1993-08-31
DE4330175A DE4330175A1 (de) 1993-08-31 1993-08-31 Alkoxy-substituierte beta-Carboline

Publications (1)

Publication Number Publication Date
CN1129938A true CN1129938A (zh) 1996-08-28

Family

ID=6497015

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94193211A Pending CN1129938A (zh) 1993-08-31 1994-08-29 作用于AMPA受体的烷氧基取代的β-咔啉

Country Status (17)

Country Link
EP (1) EP0716657A1 (de)
JP (1) JPH09501938A (de)
KR (1) KR960704888A (de)
CN (1) CN1129938A (de)
AU (1) AU7530394A (de)
CA (1) CA2170615A1 (de)
CZ (1) CZ50596A3 (de)
DE (1) DE4330175A1 (de)
FI (1) FI960940A (de)
HU (1) HUT73845A (de)
IL (1) IL110745A0 (de)
NO (1) NO960812D0 (de)
NZ (1) NZ271615A (de)
PL (1) PL313230A1 (de)
SK (1) SK23896A3 (de)
WO (1) WO1995006647A1 (de)
ZA (1) ZA946670B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125942A (en) 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
EP4092013A1 (de) 2017-06-20 2022-11-23 Imbria Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur erhöhung der effizienz des herzmetabolismus
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3545776A1 (de) * 1985-12-20 1987-06-25 Schering Ag 5-aminoalkyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
DE3608089A1 (de) * 1986-03-08 1987-09-10 Schering Ag Heteroaryl-oxy-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
IL87563A (en) * 1987-08-28 1993-08-18 Schering Ag Isoxazole-b-carboline derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE3943225A1 (de) * 1989-12-23 1991-06-27 Schering Ag Neue ss-carboline, verfahren zu deren herstellung und deren verwendung in arzneimitteln
US5350750A (en) * 1991-04-27 1994-09-27 Schering Aktiengesellschaft β-carboline-3-hydroxyalkylcarboxylic acid ester derivatives, process for their production and their use in pharmaceutical agents
DE4118741A1 (de) * 1991-06-05 1992-12-10 Schering Ag Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
DE4120109A1 (de) * 1991-06-15 1992-12-17 Schering Ag 3-aryl- oder 3-hetaryl-(beta)-carboline, deren herstellung und verwendung in arzneimitteln
DE4130933A1 (de) * 1991-09-13 1993-03-18 Schering Ag Neue (beta)-carbolinderivate, deren herstellung und verwendung in arzneimitteln
DE4212529A1 (de) * 1992-04-10 1993-10-14 Schering Ag Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten

Also Published As

Publication number Publication date
NO960812L (no) 1996-02-28
CA2170615A1 (en) 1995-03-09
NO960812D0 (no) 1996-02-28
NZ271615A (en) 1996-09-25
AU7530394A (en) 1995-03-22
ZA946670B (en) 1995-04-21
FI960940A0 (fi) 1996-02-28
HUT73845A (en) 1996-09-30
HU9600505D0 (en) 1996-04-29
PL313230A1 (en) 1996-06-10
DE4330175A1 (de) 1995-03-02
CZ50596A3 (en) 1996-06-12
IL110745A0 (en) 1994-11-11
FI960940A (fi) 1996-02-28
WO1995006647A1 (de) 1995-03-09
JPH09501938A (ja) 1997-02-25
EP0716657A1 (de) 1996-06-19
KR960704888A (ko) 1996-10-09
SK23896A3 (en) 1996-11-06

Similar Documents

Publication Publication Date Title
JP6211530B2 (ja) 含窒素複素環化合物
RU2518073C2 (ru) Новое бициклическое гетероциклическое соединение
EP1339406B1 (de) Piperazin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
JP7095106B2 (ja) オキサジアゾール一過性受容器電位チャネル阻害剤
CZ283680B6 (cs) Nové azaheterocyklylmethyl-chromany
US20070259888A1 (en) Novel Compounds
EP1951709B1 (de) Imidazolidinon-verbindungen als beta-secretase-hemmer zur behandlung von alzheimer
HU219911B (hu) Pirazolo-piridin-származékok, alkalmazásuk és ezeket tartalmazó gyógyászati készítmények
KR102441634B1 (ko) 알도스테론 신타아제 억제제
CA3015702A1 (en) 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
KR20100052528A (ko) 무스카린성 수용체의 효능제로서의 피페리딘 유도체
JP6173431B2 (ja) モルヒナン誘導体
CN1252798A (zh) 5-羟色胺能试剂吲哚唑酰胺化合物
CN102639526B (zh) 作为5-ht4受体配体的1,2-二氢-2-氧代喹啉化合物
CN1145618A (zh) 新的哌啶-衍生物
KR20170032459A (ko) 알도스테론 신타아제 억제제
JP2000505461A (ja) 胃運動機能調整特性を有する新規n―置換4―((4’―アミノベンゾイル)オキシメチル)ピペリジン類
CN1129938A (zh) 作用于AMPA受体的烷氧基取代的β-咔啉
CA2030051C (en) Indole derivatives
TW202313002A (zh) 醫藥組成物,及s1p介入性疾病之預防及/或治療劑
CZ91897A3 (en) Derivatives of n-substituted piperidinyl bicyclic benzoates
AU2009244944A1 (en) Muscarinic receptor agonits useful in the treatment of pain, Alzheimer's disease and schizophrenia
CZ281714B6 (cs) Piperidylmethylsubstituované deriváty chromanu
KR20190009792A (ko) 통증에 대한 다중 활성을 갖는 테트라하이드로피란 및 티오피란 유도체
CN100534983C (zh) 环胺衍生物、其制备方法以及包含该化合物的药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication